You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Univ Az Cancer Ctr Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for UNIV AZ CANCER CTR

UNIV AZ CANCER CTR has one approved drug.



Summary for Univ Az Cancer Ctr
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Univ Az Cancer Ctr

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 DISCN No No ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 1 of 1 entries

Expired US Patents for Univ Az Cancer Ctr

ApplicantTradenameGeneric NameDosageNDAApproval DatePatent No.Patent Expiration
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 4,695,590 ⤷  Try for Free
Univ Az Cancer Ctr ACTINEX masoprocol CREAM;TOPICAL 019940-001 Sep 4, 1992 5,008,294 ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>Patent No.>Patent Expiration
Showing 1 to 2 of 2 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: University of Arizona Cancer Center - Market Position, Strengths & Strategic Insights

The University of Arizona Cancer Center (UACC) stands as a beacon of hope and innovation in the fight against cancer. As the only National Cancer Institute-designated Comprehensive Cancer Center headquartered in Arizona, UACC plays a pivotal role in advancing cancer research, treatment, and prevention[3]. This article delves into the competitive landscape of UACC, exploring its market position, strengths, and strategic insights that set it apart in the pharmaceutical and healthcare industry.

UACC's Unique Market Position

UACC's market position is characterized by its exclusive status and comprehensive approach to cancer care. As one of only 56 NCI-designated Comprehensive Cancer Centers in the United States, UACC holds a distinguished position in the oncology field[3]. This designation is a testament to the center's commitment to cutting-edge research, innovative treatments, and community outreach.

Regional Leadership and National Recognition

UACC's influence extends beyond Arizona, making it a regional resource and national model for cancer care. The center's focus on overcoming cancer risks, improving treatments through transdisciplinary discoveries, and engaging communities sets it apart from competitors[3]. This comprehensive approach not only addresses immediate patient needs but also contributes to the broader goal of advancing cancer research and treatment on a national scale.

Strategic Partnerships Enhancing Market Presence

One of UACC's key strengths lies in its strategic partnerships. The center's clinical affiliation with Banner – University Medicine in Tucson enhances its ability to provide top-tier patient care[3]. This collaboration allows UACC to bridge the gap between research and clinical practice, ensuring that patients benefit from the latest advancements in cancer treatment.

UACC's Competitive Advantages

UACC's competitive edge in the pharmaceutical landscape is built on several key strengths that position it as a leader in cancer research and treatment.

Comprehensive Research Programs

The center boasts three established scientific Research Programs that work collaboratively to fulfill its mission[6]. These programs focus on various aspects of cancer research, from basic science to clinical applications, ensuring a holistic approach to cancer care and research.

Specialization in Key Cancer Types

UACC has established itself as a leader in research on specific cancer types, including:

  • Women's cancers (breast, ovarian)
  • Men's cancers (prostate)
  • Gastrointestinal cancers (colon, pancreas, liver)
  • Lymphoma
  • Skin cancers[7]

This specialization allows UACC to develop deep expertise in these areas, attracting both patients and research funding.

Robust Cancer Prevention and Control Program

UACC is home to one of the largest Cancer Prevention and Control Programs among comprehensive cancer centers nationwide. This program leads prevention research in breast, colon, lung, prostate, and skin cancers[7], positioning UACC at the forefront of cancer prevention efforts.

Strategic Insights Driving UACC's Success

UACC's success is not just a result of its current strengths but also its forward-thinking strategies that ensure continued growth and impact in the competitive pharmaceutical landscape.

Focus on Precision Medicine

UACC's participation in the Precision Medicine Initiative, supported by a significant NIH grant, demonstrates its commitment to personalized cancer treatment[2]. This focus on precision medicine aligns with industry trends and positions UACC as a leader in tailored cancer therapies.

"As oncology continues to move toward individualized medicine, it is critical that we develop capabilities to accurately profile cancerous tumors and identify effective treatments, ultimately improving patient care and survival."[1] - Andrew Kraft, M.D., UACC Director

Emphasis on Translational Research

UACC's strategy of coupling academic planning with research planning and campus development ensures that research findings are quickly translated into clinical applications[2]. This integrated approach accelerates the pace of innovation and improves patient outcomes.

Investment in State-of-the-Art Facilities

The center's commitment to cutting-edge technology and facilities, such as the world's largest robotic field scanner, enhances its research capabilities and attracts top talent[2]. This investment in infrastructure positions UACC to remain at the forefront of cancer research and treatment.

UACC's Impact on the Competitive Landscape

UACC's presence in the pharmaceutical and healthcare industry has a significant impact on the competitive landscape, influencing both regional and national trends in cancer care.

Setting Standards for Comprehensive Care

As a comprehensive cancer center, UACC sets high standards for integrating research, clinical care, and community outreach. This model influences other healthcare providers and research institutions, raising the bar for cancer care across the industry.

Driving Innovation in Cancer Prevention

UACC's strong focus on cancer prevention and control contributes to a shift in the industry towards preventive strategies. This approach not only improves patient outcomes but also has the potential to reduce healthcare costs associated with cancer treatment.

Attracting Top Talent and Research Funding

The center's prestigious status and comprehensive programs attract leading researchers and clinicians, as well as significant research funding. This influx of talent and resources strengthens UACC's position in the competitive landscape and drives further innovation in the field.

Challenges in the Competitive Landscape

Despite its strong position, UACC faces several challenges in the competitive pharmaceutical landscape.

Increasing Competition from Other Institutions

The presence of other renowned cancer centers, such as Mayo Clinic and MD Anderson, in the region presents a competitive challenge for UACC[5]. These institutions also offer comprehensive cancer care and compete for patients, talent, and research funding.

Evolving Healthcare Landscape

The rapidly changing healthcare environment, including shifts in healthcare policies and reimbursement models, poses challenges for UACC in maintaining its competitive edge while ensuring sustainable operations.

Keeping Pace with Technological Advancements

The fast-paced nature of technological advancements in cancer research and treatment requires continuous investment and adaptation. UACC must stay at the forefront of these developments to maintain its competitive position.

Strategies for Future Growth and Competitiveness

To maintain and enhance its competitive position, UACC can consider several strategic initiatives:

Expanding Collaborative Networks

Strengthening existing partnerships and forming new collaborations with other research institutions, pharmaceutical companies, and healthcare providers can enhance UACC's research capabilities and clinical reach.

Investing in Emerging Technologies

Continued investment in cutting-edge technologies, such as artificial intelligence for cancer diagnosis and treatment planning, can keep UACC at the forefront of innovation in cancer care.

Enhancing Community Engagement

Expanding community outreach programs and focusing on underserved populations can strengthen UACC's impact and differentiate it from competitors.

UACC's Role in Shaping the Future of Cancer Care

As a leader in cancer research and treatment, UACC has the potential to shape the future of cancer care significantly.

Advancing Personalized Medicine

UACC's focus on precision medicine and genomics positions it to lead the way in developing personalized cancer treatments, potentially revolutionizing cancer care.

Pioneering New Research Frontiers

The center's comprehensive research programs and state-of-the-art facilities enable it to explore new frontiers in cancer research, from immunotherapy to nanotechnology-based treatments.

Training the Next Generation of Oncology Professionals

UACC's role in education and training ensures a continuous pipeline of skilled oncology professionals, contributing to the overall advancement of cancer care.

Key Takeaways

  • UACC's status as the only NCI-designated Comprehensive Cancer Center in Arizona gives it a unique market position.
  • The center's strengths lie in its comprehensive research programs, specialization in key cancer types, and robust prevention efforts.
  • Strategic partnerships, focus on precision medicine, and investment in state-of-the-art facilities drive UACC's success.
  • UACC faces challenges from increasing competition and the need to adapt to a rapidly evolving healthcare landscape.
  • Future growth strategies include expanding collaborative networks, investing in emerging technologies, and enhancing community engagement.
  • UACC plays a crucial role in shaping the future of cancer care through advancing personalized medicine and pioneering new research frontiers.

FAQs

  1. What makes the University of Arizona Cancer Center unique in the competitive landscape? UACC is the only NCI-designated Comprehensive Cancer Center headquartered in Arizona, offering a comprehensive approach to cancer research, treatment, and prevention.

  2. How does UACC's focus on precision medicine impact its competitive position? The focus on precision medicine aligns UACC with industry trends, positioning it as a leader in personalized cancer therapies and attracting research funding and top talent.

  3. What role do strategic partnerships play in UACC's success? Partnerships, such as the clinical affiliation with Banner – University Medicine, enhance UACC's ability to provide top-tier patient care and bridge the gap between research and clinical practice.

  4. How does UACC's Cancer Prevention and Control Program contribute to its competitive advantage? As one of the largest such programs among comprehensive cancer centers, it positions UACC at the forefront of cancer prevention efforts, differentiating it from competitors.

  5. What are the main challenges UACC faces in maintaining its competitive edge? Key challenges include increasing competition from other renowned cancer centers, adapting to the evolving healthcare landscape, and keeping pace with rapid technological advancements in cancer research and treatment.

Sources cited: [1] https://www.carislifesciences.com/about/news-and-media/university-arizona-cancer-center-banner-university-medical-center-tucson-join-precision-oncology-alliance-powered-caris-life-sciences/ [2] https://www.azregents.edu/sites/default/files/reports/2016-UA-Comprehensive-Annual-Financial-report.pdf [3] https://phoenixmed.arizona.edu/cancer-center [6] https://cancercenter.arizona.edu [7] https://hoosiercancer.org/our-network/site/382/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.